1 completed, 1 not yet recruiting, 1 terminated. 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 1 | Terminated 1 |
Follow Ge Junbo: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Multi-center, Real-World Clinical Trial of caIMR on Two Specific Kinds of Patients. caIMR - Coronary Microvascular Dysfunction (CMD), Stable Angina Pectoris | Not yet recruiting | Ge Junbo | 508 | 2025-07-01 | 2025-04-27 | |
| A Prospective, Multi-center Clinical Trial for Evaluating the Effectiveness and Safety of Online Coronary Angiography-Derived Index of Microcirculatory Resistance (caIMR) Angiography-derived Index of Microcirculatory Resistance, Pressure wire-based Index of Microcirculatory Resistance - Coronary Microvascular Dysfunction | Completed | Ge Junbo | 116 | 2021-10-14 | 2022-04-06 | |
| Effect of Low-dose Intracoronary Reteplase on Myocardial Infarct Size During Primary Percutaneous Coronary Intervention Normal Saline, Reteplase Injection 9mg, Reteplase Injection 18mg - Acute ST-segment Elevation Myocardial Infarction | Phase 3 | Terminated | Ge Junbo | 36 | 2021-07-01 | 2023-09-14 |
Angina Pectoris (1) · Angina, Stable (1) · Angina, Unstable (1) · Myocardial Ischemia (1) · ST Elevation Myocardial Infarction (1)
Saline Solution (1) · reteplase (1)
China (2)
Junbo Ge (1) · Junbo Ge, PHD (1)